Shares of Simulations Plus Inc. (SLP) are trading about 40% below their 52-week high of $50.98, recorded last May, with the stock now hovering around $30.
The company provides cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry using both artificial intelligence (AI) and machine-learning technologies. It operates through two main segments - software and services - and serves a wide range of clients, including pharmaceutical, biotechnology, agrotechnology, and cosmetics companies, along with universities, hospitals, and government research institutions.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com